,,ib  ,union ,calendar ,no4 #ege  #aaeth
 ,,congress  #b;d ,session  ,h4 ,r4     
#efhf  ,report ,no4 #aae-gda1 ,part ,i  
,,in ,,the ,,house ,,of                 
,,representatives  ,may #g1 #bjah ,mr4  
,paulsen 7for himself1 ,mr4 ,kind1 ,mr4 
,collins of ,new ,york1 and ,mr4 ,lamb7 
introduced the following bill2 which was
 referred to the ,committee on ,energy  
and ,commerce1 and in addition to the   
,committee on ,ways and ,means1 for a   
period to be subsequently determined by 
the ,speaker1 in each case for          
consideration of such provisions as fall
 within the jurisdiction of the         
committee concerned  ,june #ab1         
#bjah;,additional sponsors3 ,mrs4       
,blackburn1 ,mr4 ,fitzpatrick1 and ,mr4 
,walden  ,june #ab1 #bjah ,reported from
 the ,committee on ,energy and ,commerce
  ,june #ab1 #bjah,the ,committee on    
,ways and ,means discharged2 committed  
to the ,committee of the ,whole ,house  
on the ,state of the ,union and ordered 
to be printed  ,a ,,bill  ,to amend     

title ,,xviii of the ,social ,security  
,act to require prescription drug plans 
under ,medicare part ,d to include      
information on the adverse effects of   
opioid overutilization and of coverage  
of nonpharmacological therapies and     
nonopioid medications or devices used to
 treat pain4  #a4 ,short title ,this    
,act may be cited as the ,medicare      
,clear ,health ,options in ,care for    
,enrollees ,act of #bjah or the         
,medicare ,,choice ,act of #bjah4  #b4  
,requiring ,medicare part ,d            
prescription drug plans to include      
information on adverse effects relating 
to opioids and coverage of              
nonpharmacological therapies and        
nonopioid medications or devices used to
 treat pain ,section #ahfj;,d-#d7;a77#a7
 of the ,social ,security ,act 7#db     
,u4,s4,c4 #aciew-#ajd7;a77#a77 is       
amended--  7#a7 in subparagraph 7,a71 by
 inserting 1 subject to subparagraph    
7,c71 before including2  7#b7 in        
subparagraph 7,b71 by adding at the end 

the following new clause3  7vi7 ,for    
plan year #bjba and each subsequent plan
 year1 subject to subparagraph 7,c71    
with respect to the treatment of pain-- 
7,i7 the adverse effects of prolonged   
opioid use2 and  7,,ii7 coverage of     
nonpharmacological therapies1 devices1  
and nonopioid medications--  7aa7 in the
 case of an ,,ma-,,pd plan under part   
,c1 under such plan2 and  7bb7 in the   
case of a prescription drug plan under  
such plan and under parts ,a and ,b4  2 
and  7#c7 by adding at the end the      
following new subparagraph3  7,c7       
,targeted provision of information ,a   
,,pdp sponsor of a prescription drug    
plan may1 in lieu of disclosing the     
information described in subparagraph   
7,b77vi7 to each enrollee under the     
plan1 disclose such information through 
mail or electronic communications to a  
subset of enrollees under the plan1 such
 as enrollees who have been prescribed  
an opioid in the previous two-year      
period4  4  ,june #ab1 #bjah ,reported  

from the ,committee on ,energy and      
,commerce,june #ab1 #bjah,the ,committee
 on ,ways and ,means discharged2        
committed to the ,committee of the      
,whole ,house on the ,state of the      
,union and ordered to be printed